Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents | Next Article »
Arteriosclerosis, Thrombosis, and Vascular Biology. 1990;10:1032-1036

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Elwood, P. C.
Right arrow Articles by Renaud, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elwood, P. C.
Right arrow Articles by Renaud, S.

Arteriosclerosis, Vol 10, 1032-1036, Copyright © 1990 by American Heart Association

ARTICLES

Whole blood impedance platelet aggregometry and ischemic heart disease. The Caerphilly Collaborative Heart Disease Study

PC Elwood, AD Beswick, DS Sharp, JW Yarnell, S Rogers and S Renaud
MRC Epidemiology Unit, Cardiff, South Wales, UK.

The Caerphilly Collaborative Heart Disease Study is based on a large cohort of men who were ages 49 to 64 years at the time of the study. We report the results for platelet aggregation measured in whole blood from a subsample of 308 men. The index of sensitivity used was the minimum concentration of adenosine diphosphate that produced a defined degree of impedance change in the Chronolog 560 aggregometer. There was a marked association between aggregation and prevalent ischemic heart disease (IHD). The odds ratios and 95% confidence intervals (CI) for prevalent IHD in men with the most sensitive platelets compared with those with the least sensitive platelets were 3.6 (95% Cl: 1.1 to 12.2) for angina; 7.3 (95% Cl: 2.0 to 24.3) for previous myocardial infarction (MI); and 2.7 (95% Cl: 1.0 to 7.6) for electrocardiogram evidence of ischemia. The confidence limits for these odds ratios are large because of the small sample size, but the estimates of odds ratio are relatively large compared to similar relationships between the traditional risk factors of serum cholesterol, blood pressure, smoking, and prevalent IHD (1.5 to 2.5). A number of factors that might confound the relationships between platelets and IHD were examined, but the associations remained statistically significant when these were taken into account.


This article has been cited by other articles:


Home page
 CLIN APPL THROMB HEMOSTHome page
S. Tsiara, M. Elisaf, I. A. Jagroop, and D. P. Mikhailidis
Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity?
Clinical and Applied Thrombosis/Hemostasis, July 1, 2003; 9(3): 177 - 190.
[Abstract] [PDF]

Home page
 PerfusionHome page
R. F Baugh
Platelets and whole blood coagulation
Perfusion, January 1, 2000; 15(1): 41 - 50.
[Abstract] [PDF]

Home page
 HeartHome page
P C Elwood, S Renaud, A D Beswick, J R O'Brien, and P M Sweetnam
Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort
Heart, December 1, 1998; 80(6): 578 - 582.
[Abstract] [Full Text]

Home page
 CirculationHome page
R. P. Tracy and P. B. Tracy
New Views on the Relationship of Plasma Lipids to Cardiovascular Disease
Circulation, March 18, 1997; 95(6): 1347 - 1348.
[Full Text]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.